home / stock / gwprf / gwprf short
Short Information | GW Pharmaceuticals (OTCMKTS:GWPRF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 23,086 |
Total Actual Volume | 45,958 |
Short Trends | |
---|---|
Cover Days | 9 |
Short Days | 8 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 1,154 |
Average Short Percentage | 41.82% |
Is there a GWPRF Short Squeeze or Breakout about to happen?
See the GWPRF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-17-2021 | $16.26 | $14.54 | $16.26 | $14.5 | 3,026 | 812 | 26.83% |
06-16-2021 | $16.5 | $16.5 | $16.5 | $16.5 | 1,136 | 640 | 56.34% |
06-15-2021 | $17 | $16.5 | $17 | $16.5 | 501 | 401 | 80.04% |
06-14-2021 | $14.15 | $14.45 | $14.76 | $14.15 | 894 | 520 | 58.17% |
06-11-2021 | $16.55 | $14 | $16.55 | $14 | 1,161 | 701 | 60.38% |
06-10-2021 | $16.75 | $16.5 | $16.75 | $16.5 | 959 | 356 | 37.12% |
06-09-2021 | $16.535 | $16.75 | $16.75 | $16.535 | 571 | 16 | 2.8% |
06-07-2021 | $17.1 | $16.5 | $17.35 | $16.5 | 1,647 | 910 | 55.25% |
06-03-2021 | $17.1 | $17.1 | $17.1 | $17.1 | 251 | 100 | 39.84% |
06-02-2021 | $16.1 | $17.1 | $17.1 | $16.1 | 2,206 | 1,018 | 46.15% |
06-01-2021 | $18 | $17.9 | $18 | $17.75 | 574 | 129 | 22.47% |
05-28-2021 | $17.95 | $17.9 | $17.95 | $16 | 3,019 | 783 | 25.94% |
05-27-2021 | $16.78 | $17.95 | $17.99 | $16.78 | 2,987 | 2,628 | 87.98% |
05-26-2021 | $16.73 | $16.78 | $16.78 | $16.73 | 1,603 | 325 | 20.27% |
05-25-2021 | $16.74 | $16.74 | $16.74 | $16.74 | 364 | 20 | 5.49% |
05-21-2021 | $16.72 | $16.73 | $17.23 | $16.72 | 777 | 116 | 14.93% |
05-17-2021 | $17.08 | $18 | $18 | $17.08 | 576 | 5 | 0.87% |
05-13-2021 | $17.635 | $17.5 | $17.8 | $17.5 | 4,505 | 3,906 | 86.7% |
05-12-2021 | $17.42 | $17.5 | $17.5 | $17.39 | 8,546 | 7,700 | 90.1% |
05-10-2021 | $17.99 | $17.39 | $18.19 | $17.39 | 10,655 | 2,000 | 18.77% |
News, Short Squeeze, Breakout and More Instantly...
GWPH stock is moving up double-digits after GW Pharmaceuticals (NASDAQ:GWPH) reported a big jump in its cannabis-derived epilepsy drug, Epidiolex. The medicine uses CBD, and it is known to be an effective treatment for some types of epilepsy. Impressive Quarterly Numbers As everyone k...
CannabisNewsWire Editorial Coverage : As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry. Sugarmade Inc. (OTCQB: SGMD) ( SGMD Profile ) is supporting many of these c...
The first passively managed, pure-play exchange-traded fund (ETF) for cannabis investing is now publicly available to investors. On Tuesday (July 9), Innovation Shares’ The Cannabis ETF (ARCA: THCX ) l aunched on NYSE Arca . The THCX focuses on companies in the legal cann...